Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gene Expression at Injection Site vs Blood for Adjuvanted Vaccines
NCT02368327Completed
- Sponsor
- University of Surrey
- Start
- Feb 2015
- Primary completion
- Jul 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Randomised trial in influenza and hepatitis B (HBV) comparing Fluad, Fendrix and Placebo (3 arms). Primary endpoint: Change from baseline values of gene expression in whole blood and muscle at Day 7. Started Feb 2015; status: completed.
02
Drugs
Fluzone TrivalentHepatitis B vaccine
03
Conditions
influenzahepatitis B (HBV)
Beyond the preview
Go deeper on NCT02368327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02368327.